Has ANDROMEDA-SHOCK-2 really changed anything at the bedside?
Join the PI of the trial and leading experts in hemodynamic resuscitation for a free live panel on June 10 at 12:00 PM PT.
🔗 https://t.co/hBD1of2F91
#CriticalCare#Sepsis#SepsisResuscitation#POCUS
Has ANDROMEDA-SHOCK-2 really changed anything at the bedside?
Join the PI of the trial and leading experts in hemodynamic resuscitation for a free live panel on June 10 at 12:00 PM PT.
🔗 https://t.co/hBD1of2F91
#CriticalCare#Sepsis#SepsisResuscitation#POCUS
Two patients. Same diagnosis. Two very different outcomes. The difference isn't luck. It's physiology, and whether clinicians are empowered to follow it.
Sepsis care is changing. Dr. Jon-Emile Kenny, our CMO, lays out the case in Emergency Medicine News for why the question before every fluid bolus should be the same one. Will the heart respond?
Read Jon's piece in the June issue of @EMNews → https://t.co/nBqect7vaW
#SepsisCare #SepsisResuscitation #FlosonicsMedical #FloPatch
How should you resuscitate sepsis post Andromeda-Shock 2?
Join us, the investigators on Andromeda-VEXUS, Andromeda-Shock 2 as we have a full throttle webinar (debate? cage match?) and settle this with a discussion of the blend of evidence and physiology.
When: June 10th 3:00pm ET (12:00pm PT)
Free Registration: https://t.co/kkIXy3Oi24
Super pumped for it!
Has ANDROMEDA-SHOCK-2 really changed anything at the bedside?
Join the PI of the trial and leading experts in hemodynamic resuscitation for a free live panel on June 10 at 12:00 PM PT.
🔗 https://t.co/hBD1of2F91
#CriticalCare#Sepsis#SepsisResuscitation#POCUS
The 2026 Surviving Sepsis Campaign guidelines are out with a clear message: dynamic, physiology-driven fluid resuscitation over static parameters.
But the tools most commonly cited to meet that standard come with limitations. We break it down: https://t.co/LTZSvZvTGm
#Sepsis #CriticalCare #FlosonicsMedical #FloPatch
@SutterHealth is expanding FloPatch to three more Bay Area hospitals, bringing real-time, personalized fluid management to more critically ill patients across Northern California.
Read the full press release: https://t.co/DAJ38iCkuT
#Sepsis#CriticalCare#FlosonicsMedical #FloPatch
Dr. Carolyn Kaufman, Stanford University School of Medicine, on the newly published SaFER protocol and how FloPatch helps make IV fluid decisions more accessible to frontline teams.
Read the full press release: https://t.co/pVIq6DgK7M
#CriticalCare#Sepsis#FlosonicsMedical #FloPatch
The SaFER protocol is now published in SN Comprehensive Clinical Medicine.
Co-authored by Dr. Carolyn Kaufman and our co-founder Dr. Jon-Emile Kenny, SaFER gives critical care teams a structured approach to IV fluid decisions: Are fluids indicated? Safe? Effective?
FloPatch makes this protocol actionable at the bedside.
Read the full press release: https://t.co/esWub2ihRa
#CriticalCare #Sepsis #FlosonicsMedical #FloPatch
A new protocol is changing how clinicians think about IV fluids.
The SaFER protocol, now published in SN Comprehensive Clinical Medicine, introduces a new paradigm: treating IV fluids like a drug by separately evaluating their safety and efficacy.
Three questions. One structured approach to modern fluid resuscitation.
Read the publication here: https://t.co/f2DdpR9lWm
#FluidManagement #CriticalCare #FlosonicsMedical #FloPatch
We're proud to announce that FloPatch has received an Innovative Technology contract from @VizientIncJobs, the nation's largest provider-driven healthcare performance improvement company.
This designation was awarded after review by hospital experts on Vizient's client-led councils, who recognized FloPatch's potential to transform how clinicians make fluid management decisions in sepsis care.
Read the full press release: https://t.co/mLVCYDcKJC
#InnovativeTechnology #SepsisCare #FlosonicsMedical #FloPatch
March is National Kidney Month.
Fluid overload remains one of the most preventable causes of acute kidney injury (AKI). Yet it still happens when fluids are given without first assessing whether a patient will actually respond.
The shift is simple:
✔️ Assess fluid responsiveness before administering fluids.
✔️ Personalize fluid management: the right amount, to the right patient, at the right time.
This #NationalKidneyMonth, let's protect kidney health through personalized fluid decisions.
#FluidManagement #CriticalCare #FlosonicsMedical #FloPatch
February is Heart Month. In critical care, some of the most consequential cardiac injury happens quietly, during fluid resuscitation.
Our latest blog explores how patient-specific fluid resuscitation can prevent cardiac stress and support recovery.
Read the blog here: https://t.co/S7JqcbSHpQ
#HeartMonth #Sepsis #FlosonicsMedical #FloPatch
Flu rates are up and sepsis often follows.
When units get busy, early resuscitation can slip into autopilot. Our latest blog looks at flu-related sepsis and why individualized fluid decisions matter.
Read the blog here: https://t.co/zFVhxTePYz
#SepsisCare#Influenza #FlosonicsMedical #FloPatch
Recognized as a 2025 Top Read from @accpchest.
Wearable Doppler-measured carotid corrected flow time accurately detects stroke volume change vs TEE after CABG.
Study by Jon-Emile S. Kenny, MD et al.
https://t.co/6hitXaoTik
#CriticalCare#Hemodynamics#FlosonicsMedical #FloPatch
February is Heart Month 🫀
This month, let’s raise awareness about heart-safe resuscitation and the role fluid decisions play in protecting the heart.
#HeartMonth#SepsisCare#FlosonicsMedical#FloPatch
More fluids aren’t always the answer in septic shock.
On the latest Rapid Response RN, Sarah Lorenzini and nurse leader Jaclyn Bond unpack ANDROMEDA-SHOCK-2 and why physiology-guided resuscitation matters at the bedside.
🎧 Listen here: https://t.co/BmoJvMDQuy
#SepsisCare #CriticalCareNursing #FlosonicsMedical #FloPatch
Do all shock patients need an arterial line? New evidence from the EVERDAC trial suggests not always.
Our latest blog breaks down what this landmark study from @NEJM means for septic shock care.
Read the blog here: https://t.co/d1pIMafGiB
#ShockCare#CriticalCare #FlosonicsMedical #FloPatch